The Silencer

The Investigational Drug Program (IDP) at the BC Cancer Agency offers fee-for-service preclinical research and contract manufacturing services to both academic and private sector researchers. With a focus on cancer therapeutics, IDP collaborates closely with its partners to advance promising therapeutic compounds to the stage of early-phase human clinical trials. Equipped with fully compliant GLP and GMP facilities, IDP has successfully produced over 130 distinct batches of injectable experimental drug formulations. The program's highly skilled team provides comprehensive management of in vitro and in vivo research services, ensuring timely and cost-effective guidance for product development through established relationships with oncology specialists. Generated from the website

The Friedman Lab is a translational research group within the University of British Columbia's Department of Medical Genetics, located at the Children's and Women's Health Centre in Vancouver, Canada. Led by Professor Jan M. Friedman, the lab comprises a multidisciplinary team of experts in clinical genetics, clinical genomics, clinical teratology, genetic counselling, and health services research. The group's primary objective is to enhance the care of families affected by genetic disorders, focusing on three key areas: the genetic causes of intellectual disability, neurofibromatosis, and birth defect epidemiology. All research conducted at the Friedman Lab is collaborative, aiming to advance understanding and treatment in these critical fields. Generated from the website

I G MicroMed Environmental Inc in Richmond is a Council of Canada accredited business, providing microbiology testing and analysis. We also provide commercial product analysis. For more information about our services, please call us today.